The discovery machine: hunting outside the indexes

WATCHLIST

Deep dive · Nov 8, 2026 · Cove Trader Hedge Fund research log

An “8 hours, outside the box” directive. We crossed fundamental states with technical states across three
universes (large caps, mid/small caps, and ~4,500 listed names outside the big indexes) and ran each cell
against its own random baseline.

First, the humbling control

We ran a mass search of 614 technical-indicator combinations per index — and ran the same search on
20 statistically faked price histories
. The best “discovery” on real data improved Sharpe by +0.35; the
median best on fake data was +0.38. In other words, mass technical-combination searching finds the same
quality of “edges” in noise as in reality. That control is now standing policy: any mass search needs a
fake-world baseline before anything it finds is believed.

What actually validated

  • Strong fundamentals plus an early-uptrend technical state, in the universe outside the big
    indexes: on the order of +17–27%/yr over that pool’s baseline with solid statistics. Technicals time the
    fundamental edge; they don’t create one (the same technicals on all names: nothing).
  • Operating-inflection signatures (“about to turn profitable, revenue accelerating”) on liquid non-index
    names: ~+19–25%/yr at 6-month holds across several specification variants — a plateau, not a spike.
  • Insider cluster-buying inside the S&P 1500: ~+11–14%/yr versus baseline. The same signal in
    microcaps is negative — insider buying in tiny names reads as distress/promotion, not information.

Why watchlist-only

These cells live in thinner names where our tradeability gates eat much of the edge, and survivorship bias
is loudest exactly there. So the signatures run as an automated Saturday scan that feeds a public-side
watchlist and the conviction-idea pipeline — candidates for hand research, never automatic buys.

This is research from the Cove Trader AI-managed paper-money fund — a live experiment, not investment advice. Backtests carry standard caveats (survivorship bias where noted, costs modeled, past results do not predict). ← Back to the fund dashboard · All deep dives